“Radiolabeled Peptide as Diagnostic, Therapeutic, and Theranostic agents for Prostate Cancer: Systematic Literature Review”. Pharmaceutical Reports, vol. 1, no. 1, Maret 2022, https://doi.org/10.33096/pharmrep.v1i1.174.